alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive

C Kluft1, H K Nieuwenhuis, D C Rijken

  • 1Gaubius Institute, Leiden, The Netherlands.

Insights

Congenital absence of alpha 2-antiplasmin (alpha 2-AP) causes bleeding disorders. This study identifies a novel alpha 2-AP Enschede variant with defective plasmin inhibition but normal plasminogen binding, inherited in an autosomal recessive pattern.

Area of Science:

  • Hematology
  • Biochemistry
  • Genetics

Background:

  • Alpha 2-antiplasmin (alpha 2-AP) is a critical inhibitor of fibrinolysis.
  • Complete congenital absence of alpha 2-AP is linked to hemorrhagic diathesis.
  • This study investigates a family with a bleeding disorder and abnormal alpha 2-AP levels.

Observation:

  • A 15-year-old male presented with a lifelong hemorrhagic diathesis.
  • He exhibited minimal functional alpha 2-AP activity (≤4% of normal) but normal antigen levels (83%).
  • Similar findings were observed in his sister and eight other family members identified as heterozygotes.

Findings:

  • The propositus had a homozygous defect, designated alpha 2-AP Enschede, with normal immunological and molecular characteristics but defective plasmin and trypsin inhibition.
  • Alpha 2-AP Enschede demonstrated normal plasminogen binding and Factor XIII-mediated fibrin binding.
  • Heterozygotes showed normal function of residual normal alpha 2-AP, unaffected by the abnormal variant.

Implications:

  • Alpha 2-AP Enschede represents a novel molecular defect in plasmin inhibition.
  • Inherited abnormal alpha 2-AP molecules, even with preserved plasminogen binding, do not prevent hemorrhagic diathesis.
  • Understanding these defects is crucial for diagnosing and managing bleeding disorders.

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
20.5K
Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
2.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
20
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
30